MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Deep brain stimulation (DBS)"

  • 2019 International Congress

    Treatment approaches for infection following DBS

    F. Yuzbasi, H. Kaptan (Izmir, Turkey)

    Objective: We retrospectively reviewed all infection following DBS surgeries performed in a 4-year period Background: Infection is one of the most common complications of deep…
  • 2019 International Congress

    Is awake physiological confirmation necessary for DBS treatment of Parkinson’s disease today? A comparison of intraoperative imaging, physiology, and physiology imaging-guided DBS in the past decade

    GH. Lu, ZX. Yin, YY. Luo, YW. Jin (Nanchang, China)

    Objective: To comprehensively compare the use of IMG-DBS, PHY-DBS and COMB-DBS in treating PD. Background: Deep brain stimulation (DBS) is a well-established surgical therapy for…
  • 2019 International Congress

    Efficacy of carbidopa/levodopa enteral suspension (CLES) in advanced Parkinson’s disease patients previously treated with deep brain stimulation (DBS) – A subgroup analysis from PROviDE study

    S. Isaacson, R. Pahwa, S. Thakkar, P. Kandukuri, Y. Jalundhwala, P. Kukreja, Y. Bao, N. Gupta, I. Pan, J. Aldred (Boca Raton, FL, USA)

    Objective: To evaluate the effectiveness of carbidopa/levodopa enteral suspension (CLES) on patients with advanced Parkinson’s disease who had previously undergone deep brain stimulation (DBS). Background:…
  • 2019 International Congress

    Evidence of survival and integration of implanted autologous peripheral nerve graft in substantia nigra in a patient with Parkinson’s disease

    DR. Ginjupally, G. Quintero, Z. Guduru, J. Gurwell, J. Slevin, A. Granholm, G. Gerhardt, C. van Horne (Denver, CO, USA)

    Objective: We report a patient with Parkinson’s disease (PD) who underwent deep brain stimulation (DBS) simultaneously with peripheral nerve graft in substantia nigra (SN) and the…
  • 2019 International Congress

    DBS Programming In Tremor And Akinetic-Rigid Predominant Parkinson’s Disease

    Z. Guduru, D. Ginjupally, T. Ali, N. El Seblani, J. Quintero, C. van Horne (Lexington, KY, USA)

    Objective: Deep brain stimulation (DBS) targeting Globus pallidus pars interna (GPi) and subthalamic nucleus (STN) is an established surgical treatment for Parkinson’s disease (PD). Due…
  • 2019 International Congress

    A novel intermittent control paradigm to investigate oscillatory neuronal activity in the STN

    M. Boca, N. Ray, C. Kobylecki, J. Evans, I. Loram, M. Silverdale (Manchester, United Kingdom)

    Objective: To present a new methodology of recording STN local field potential (LFP) activity. Background: Recordings of LFPs from the subthalamic nucleus (STN) of patients…
  • 2019 International Congress

    A novel heterozygous ANO3 mutation responsible for myoclonus-dystonia

    C. Laurencin, E. Broussolle, T. Danaila, M. Anheim, J. Chelly, S. Thobois (Lyon, France)

    Objective: We present a family carrying ANO3 mutation and exhibiting a myoclonus-dystonia and tremor phenotype. Background: Mutations of Anoctamine 3 gene (ANO3) are a rare…
  • 2019 International Congress

    ADL impairment and quality of life in patients with essential tremor

    P. Reker, S. Schnitzler, T. Thies, A. Josten, J. Becker, J. Steffen, J. Wirths, H. Dafsari, V. Visser-Vandewalle, M. Barbe (Cologne, Germany)

    Objective: To investigate the relationship of tremor severity, disease related quality of life (QoL) and impairment of activities of daily living (ADL) in patients with…
  • 2019 International Congress

    Multimodal PET and fcMRI reveals regional modulation by STN DBS correlating to motor outcomes

    J. Younce, A. Tanenbaum, M. Campbell, J. Perlmutter, S. Norris (St Louis, MO, USA)

    Objective: To define brain networks modulated by deep brain stimulation (DBS) of the subthalamic nucleus (STN) and correlate connectivity with motor outcomes. Background: STN DBS…
  • 2019 International Congress

    Evaluating Perceptions of Deep Brain Stimulation in DBS-naïve Patients with Parkinson’s Disease – A Pilot Study

    S. Das, S. Ramesh, M. Baldassari, M. Rasool, J. Ratliff, D. Kremens, T. Alexander, C. Matias, TW. Liang, C. Wu (Philadelphia, PA, USA)

    Objective: To examine perceptions of Deep Brain Stimulation (DBS) in patients with Parkinson’s Disease (PD), with the aim of understanding common fears and concerns about…
  • « Previous Page
  • 1
  • …
  • 107
  • 108
  • 109
  • 110
  • 111
  • …
  • 169
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • #24970 (not found)
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • An atypical and interesting feature of Parkinson´s disease
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley